Definition and Classification
Penicillins are a major subclass of beta-lactam antibiotics, originally derived from Penicillium fungi, and represent one of the most historically important and widely used classes of antimicrobial agents. They work by inhibiting bacterial cell wall synthesis, leading to bacterial cell lysis and death. As bactericidal agents, penicillins are effective against many Gram-positive organisms, some Gram-negative organisms, and anaerobes, depending on the specific subclass.
Penicillins are divided into several groups based on their antimicrobial spectrum and resistance to beta-lactamases:
-
Natural Penicillins
-
Aminopenicillins
-
Penicillinase-resistant (anti-staphylococcal) penicillins
-
Extended-spectrum (anti-pseudomonal) penicillins
-
Penicillins combined with beta-lactamase inhibitors (covered in a previous entry)
1. Mechanism of Action
Penicillins inhibit the final stage of bacterial peptidoglycan synthesis by binding irreversibly to penicillin-binding proteins (PBPs) on the bacterial cell wall. This disrupts cross-linking of the peptidoglycan chains, leading to weakening of the wall, osmotic instability, and cell death. Their action is time-dependent and requires active bacterial growth.
2. Classification of Penicillins and Their Properties
Group | Examples | Spectrum | Notable Characteristics |
---|---|---|---|
Natural Penicillins | Penicillin G, Penicillin V | Narrow; mainly Gram-positive cocci and anaerobes | Susceptible to beta-lactamases |
Aminopenicillins | Amoxicillin, Ampicillin | Extended Gram-negative activity | Still beta-lactamase susceptible |
Penicillinase-resistant Penicillins | Cloxacillin, Dicloxacillin, Flucloxacillin, Nafcillin | Narrow; MSSA and Streptococcus spp. | Stable against staphylococcal beta-lactamase |
Extended-spectrum Penicillins | Piperacillin, Ticarcillin | Broad spectrum, including Pseudomonas spp. | Usually paired with beta-lactamase inhibitors in clinical use |
3. Natural Penicillins
a. Penicillin G (Benzylpenicillin)
-
Route: IV/IM
-
Acid-labile, not suitable for oral use
-
Indications: Syphilis, meningitis (caused by Neisseria meningitidis), streptococcal pharyngitis, diphtheria, actinomycosis
b. Penicillin V (Phenoxymethylpenicillin)
-
Route: Oral
-
Acid-stable
-
Indications: Streptococcal pharyngitis, mild skin infections, dental infections
4. Aminopenicillins
a. Amoxicillin
-
Route: Oral
-
Better oral bioavailability than ampicillin
-
Indications: Otitis media, sinusitis, bronchitis, dental abscess, Helicobacter pylori eradication (with clarithromycin and PPI)
b. Ampicillin
-
Route: Oral, IV
-
Broader use in hospital settings
-
Indications: Listeria monocytogenes infections (e.g., meningitis), enterococcal infections, respiratory tract infections
5. Penicillinase-Resistant Penicillins (Anti-Staphylococcal Penicillins)
Designed to resist inactivation by staphylococcal beta-lactamases.
Examples:
-
Cloxacillin (oral, IM/IV)
-
Dicloxacillin (oral)
-
Flucloxacillin (oral, IV)
-
Nafcillin, Oxacillin (IV)
Indications:
-
Skin and soft tissue infections (SSTIs) due to MSSA
-
Osteomyelitis
-
Septic arthritis
-
Endocarditis
These drugs do not cover MRSA (methicillin-resistant Staphylococcus aureus).
6. Extended-Spectrum Penicillins
Primarily used in hospital settings due to broader Gram-negative activity, including Pseudomonas aeruginosa.
a. Piperacillin
-
Usually combined with tazobactam (see beta-lactamase inhibitor combinations)
-
IV use only
b. Ticarcillin
-
Rarely used alone
-
Combined with clavulanic acid (Timentin – now discontinued in many markets)
Indications:
-
Severe hospital-acquired infections
-
Intra-abdominal infections
-
Febrile neutropenia
-
Complicated UTIs and SSTIs
7. Pharmacokinetics
Property | Details |
---|---|
Absorption | Varies by drug; amoxicillin is well absorbed orally; penicillin G is IV only |
Distribution | Good tissue penetration; limited CNS penetration unless meninges are inflamed |
Protein binding | Moderate to high |
Metabolism | Minimal hepatic metabolism |
Excretion | Primarily renal (glomerular filtration and tubular secretion) |
Half-life | Short (generally < 2 hours) |
8. Dosage Examples
Drug | Typical Adult Dose | Route |
---|---|---|
Penicillin V | 250–500 mg every 6–8 hours | Oral |
Amoxicillin | 500–875 mg every 8–12 hours | Oral |
Ampicillin | 1–2 g every 4–6 hours | IV |
Flucloxacillin | 250–500 mg every 6 hours | Oral or IV |
Piperacillin (alone) | 3–4 g every 6–8 hours (rare as monotherapy) | IV |
9. Adverse Effects
System Affected | Common Adverse Effects |
---|---|
Gastrointestinal | Nausea, vomiting, diarrhea (esp. amoxicillin) |
Hypersensitivity reactions | Urticaria, angioedema, anaphylaxis |
Hematologic | Neutropenia, thrombocytopenia (rare, usually with prolonged use) |
Hepatic | Cholestatic hepatitis (esp. with flucloxacillin) |
CNS (high doses or renal impairment) | Seizures, encephalopathy |
Renal | Interstitial nephritis (rare) |
10. Contraindications and Cautions
Contraindication | Explanation |
---|---|
Severe allergy to penicillins | Cross-reactivity with other beta-lactams possible |
Previous cholestatic jaundice (amoxicillin-clavulanate) | Avoid re-exposure |
Renal impairment | Dose adjustment required to avoid accumulation |
11. Drug Interactions
Drug/Class | Interaction |
---|---|
Methotrexate | Reduced excretion; increased methotrexate toxicity |
Allopurinol | Increased risk of rash (especially with ampicillin) |
Oral contraceptives | May reduce efficacy (altered gut flora) |
Probenecid | Inhibits renal excretion, increasing serum penicillin levels |
Aminoglycosides (IV) | Can be synergistic against some bacteria |
12. Resistance Mechanisms
Mechanism | Details |
---|---|
Beta-lactamase production | Common in Gram-negative and Staphylococcus aureus |
PBP alterations | MRSA produces PBP2a; Streptococcus pneumoniae may alter PBP structure |
Efflux pumps | Found in some Gram-negative organisms |
Porin loss | Decreased permeability in Gram-negative outer membranes |
13. Clinical Use by Infection Type
Infection | Preferred Penicillin |
---|---|
Strep throat | Penicillin V |
Otitis media, sinusitis | Amoxicillin |
Syphilis | Penicillin G (IM or IV) |
MSSA skin infection | Flucloxacillin, Cloxacillin |
Dental abscess | Amoxicillin, Phenoxymethylpenicillin |
Listeria meningitis | Ampicillin |
Endocarditis (Strep viridans) | Penicillin G |
Animal bite | Amoxicillin-clavulanate |
14. Special Populations
Group | Recommendation |
---|---|
Pregnancy | Generally safe; Category B |
Children | Widely used; amoxicillin is first-line for many infections |
Renal impairment | Adjust dose to prevent toxicity |
Hepatic disease | Monitor LFTs if using flucloxacillin |
15. Advantages of Penicillins
-
Highly effective against many Gram-positive pathogens
-
Low toxicity profile
-
Multiple oral and parenteral options
-
Well-studied safety in pregnancy and pediatrics
-
Broad clinical experience and guidelines supporting use
16. Limitations
-
Widespread resistance limits monotherapy in many infections
-
Allergic reactions limit use in some patients
-
Short half-life requires frequent dosing
-
Beta-lactamase susceptibility necessitates combination therapy in many cases
17. Notable Penicillin Derivatives (Beyond Traditional Forms)
Drug | Formulation | Notes |
---|---|---|
Benzathine penicillin G | Long-acting IM injection | Used for syphilis (single-dose treatment) |
Procaine penicillin G | Intermediate-acting IM injection | Formerly used in streptococcal infections |
No comments:
Post a Comment